Home > M&A deals 2018 > Supernus Pharmaceuticals, Inc. acquires Biscayne Neurotherapeutics, Inc.
Add-on Acquistion · Life Science · September 2018

Supernus Pharmaceuticals, Inc. acquires Biscayne Neurotherapeutics, Inc.

On September 13, 2018, Supernus Pharmaceuticals, Inc. acquired Biscayne Neurotherapeutics, Inc., a life science company in Florida, United States.

Deal at a glance

AnnouncedSeptember 13, 2018 TypeAdd-on Acquistion TargetBiscayne Neurotherapeutics, Inc. Buyer Supernus Pharmaceuticals, Inc. SectorLife Science LocationFlorida, United States ValueMembers only

Target company

Biscayne Neurotherapeutics, Inc.
Florida, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Supernus Pharmaceuticals, Inc.
Company · 3 deals on record
  • 1st transaction in life science
  • 1st transaction in United States
3deals, all time
2in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Biscayne Neurotherapeutics, Inc.?Supernus Pharmaceuticals, Inc. acquired Biscayne Neurotherapeutics, Inc. on September 13, 2018.

What type of deal was it?It was a add-on acquistion in the life science sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).